DRUG-INDUCED ANTIBODIES DURING 2-N-METHYL-9-HYDROXYELLIPTICINIUM ACETATE (NSC-264137) TREATMENT - SCHEDULE DEPENDENCY AND RELATIONSHIP TO HEMOLYSIS

被引：14

作者：

MONDESIR, JM

BIDART, JM

GOODMAN, A

ALBERICI, GF

CAILLE, P

TROALEN, F

ROUESSE, J

BOHUON, C

GRALLA, RJ

EINZIG, AI

BUZDAR, AU

机构：

[1] SANOFI RECH, PARIS, FRANCE

[2] INST GUSTAVE ROUSSY, DEPT BIOL CLIN, F-94805 VILLEJUIF, FRANCE

[3] INST GUSTAVE ROUSSY, DEPT MED ADULTE, F-94805 VILLEJUIF, FRANCE

[4] MEM SLOAN KETTERING CANC CTR, DEV CHEMOTHERAPY SERV, NEW YORK, NY 10021 USA

[5] MEM SLOAN KETTERING CANC CTR, SOLID TUMOR SERV, NEW YORK, NY 10021 USA

[6] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, DEPT MED, HOUSTON, TX 77030 USA

[7] IVES LABS INC, 685 THIRD AVE, 20TH FLOOR, NEW YORK, NY 10017 USA

来源：

关键词：

D O I：

10.1200/JCO.1985.3.5.735

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：735 / 740

页数：6